JUSTIN BLUMREICH: Open Payments
NPI 1578974010 · REDDING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,379 in 119 payments from 15 companies in 2025. Trend: 2023 $6,221 · 2024 $7,292 · 2025 $8,379
Consulting: $3,950Food & beverage: $2,619Speaker / faculty: $1,650Education: $160
| Company | Payments | Amount |
|---|---|---|
| Eli Lilly and Company | 2 | $3,150 |
| Galderma Laboratories, L.P. | 13 | $1,992 |
| ABBVIE INC. | 39 | $1,326 |
| LEO Pharma Inc. | 13 | $334 |
| GENZYME CORPORATION | 10 | $320 |
| Novartis Pharmaceuticals Corporation | 14 | $259 |
| Janssen Biotech, Inc. | 6 | $226 |
| Incyte Corporation | 4 | $202 |
| Organon LLC | 2 | $187 |
| Regeneron Healthcare Solutions, Inc. | 7 | $178 |
Products named: EBGLYSS, NEMLUVIO, RINVOQ, DUPIXENT, ADBRY, TREMFYA, OPZELURA, VTAMA.
Industry payments across CA — which companies pay providers there.
